Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharmatimes.com
PharmaTimes: News RSS
Get the latest updates from PharmaTimes: News RSS directly as they happen.
Follow now 135 followers
Latest posts
Last updated 2 days ago
UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
2 days ago
Partnership builds on existing collaboration and adds two new UCB‑nominated projects
Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
2 days ago
Nihr‑funded phase 2 study to assess progesterone delivery using Callavid device
Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
4 days ago
Findings support once‑daily dosing and reinforce PALI‑2108’s potential
MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
4 days ago
Study expands evaluation of survivin‑targeting vaccine
Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
9 days ago
UK spin‑out speeds up development and reduces animal testing
Subcutaneous pembrolizumab begins rollout across NHS hospitals
9 days ago
New one‑to‑two‑minute injection offers faster option for patients
Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
9 days ago
Boehringer Ingelheim reports significant reductions in weight
Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
10 days ago
Partnership to support selection of first neoantigen therapy candidate
BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
10 days ago
Collaboration aims to create integrated platform from discovery to IND submission
Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
11 days ago
Lead asset shows systemic, dose‑dependent anti‑tumour activity
Theolytics announces first patient dosed in the Octopod‑IP trial
11 days ago
US study marks company’s second clinical trial of ovarian cancer therapy
UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
12 days ago
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants